Neutrophil-lymphocyte ratio at 14th week predicts loss ofresponse to 52-week infliximab therapy in patients withCrohn’s disease
高 倩,董红霞,李 瑾
Journal of Southern Medical University . 2020, (04): 453 -458 .  DOI: 10.12122/j.issn.1673-4254.2020.04.01